PhenomeX (PhenomeX) Debt-to-Equity : 0.26 (As of Jun. 2023)

View and export this data going back to 2020. Start your Free Trial

What is PhenomeX Debt-to-Equity?

PhenomeX's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was $5.02 Mil. PhenomeX's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was $23.95 Mil. PhenomeX's Total Stockholders Equity for the quarter that ended in Jun. 2023 was $111.28 Mil. PhenomeX's debt to equity for the quarter that ended in Jun. 2023 was 0.26.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for PhenomeX's Debt-to-Equity or its related term are showing as below:

CELL' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.13 Med: 0.25 Max: 0.63
Current: 0.26

During the past 5 years, the highest Debt-to-Equity Ratio of PhenomeX was 0.63. The lowest was 0.13. And the median was 0.25.

CELL's Debt-to-Equity is not ranked
in the Biotechnology industry.
Industry Median: 0.145 vs CELL: 0.26

PhenomeX Debt-to-Equity Historical Data

The historical data trend for PhenomeX's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PhenomeX Debt-to-Equity Chart

PhenomeX Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Debt-to-Equity

0.20

0.34

0.15

0.23

0.32

PhenomeX Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Debt-to-Equity	Get a 7-Day Free Trial														0.27	0.30	0.32	0.63	0.26

Competitive Comparison of PhenomeX's Debt-to-Equity

For the Biotechnology subindustry, PhenomeX's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PhenomeX's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PhenomeX's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where PhenomeX's Debt-to-Equity falls into.

PhenomeX Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

PhenomeX's Debt to Equity Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(8.257	+	37.586)	/	142.055
	=	0.32

PhenomeX's Debt to Equity Ratio for the quarter that ended in Jun. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(5.018	+	23.95)	/	111.281
	=	0.26

PhenomeX (NAS:CELL) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

PhenomeX Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of PhenomeX's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

PhenomeX (PhenomeX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PhenomeX Inc (NAS:CELL) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

5858 Horton Street, Suite 320, Emeryville, CA, USA, 94608

Website

https://www.phenomex.com

PhenomeX Inc is a functional cell biology company that provides live cell biology research tools which deliver deep insights into cellular function and new perspectives on phenomes.

Executives

Siddhartha Kadia	director, officer: Chief Executive Officer	7475 LUSK BOULEVARD, SAN DIEGO CA 92121
Mehul Joshi	officer: Chief Financial Officer	C/O BERKELEY LIGHTS, INC., 5858 HORTON STREET, SUITE 320, EMERYVILLE CA 94608
Peter Silvester	director	C/O BERKELEY LIGHTS, INC., 5858 HORTON STREET, SUITE 320, EMERYVILLE CA 94608
John R Chiminski	director	C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873
Jessica Hopfield	director	C/O 600 TECHNOLOGY PARK DRIVE, SUITE 200, BILLERICA MA 01821
Bird Mergersub Corp	10 percent owner	40 MANNING ROAD, BILLERICA MA 01821
Bruker Corp	10 percent owner	40 MANNING RD, BILLERICA MA 01821
James Paul Mcclaskey	officer: SVP, Chief Accounting Officer	C/O BERKELEY LIGHTS, INC., C/O BERKELEY LIGHTS, INC., EMERYVILLE CA 94608
Scott David Chaplin	officer: Chief Legal Officer	3101 WILSON BOULEVARD, SUITE 700, ARLINGTON VA 22201
Eric Hobbs	director, officer: Chief Executive Officer	C/O BERKELEY LIGHTS, INC., 5858 HORTON STREET, SUITE 320, EMERYVILLE CA 94608
James Rothman	director	135 EAST 83RD STREET, APT. 15C, NEW YORK NY 10028
Gregory T Lucier	director	C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Keith Breinlinger	officer: Chief Technical Officer	C/O BERKELEY LIGHTS, INC., 5858 HORTON STREET, SUITE 320, EMERYVILLE CA 94608
Igor Y Khandros	director, 10 percent owner	25 HACIENDAS ROAD, ORINDA CA 94563
Stuart L Merkadeau	officer: General Counsel	7005 SOUTHFRONT ROAD, LIVERMORE CA 94551